• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expanding research to provide an evidence base for nutritional interventions for the management of inborn errors of metabolism.扩大研究范围,为代谢性先天缺陷的营养干预管理提供证据基础。
Mol Genet Metab. 2013 Aug;109(4):319-28. doi: 10.1016/j.ymgme.2013.05.008. Epub 2013 May 23.
2
Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning.通过新生儿筛查确定的先天性代谢缺陷:用于研究议程规划的十年发病率数据及营养干预成本
Mol Genet Metab. 2014 Sep-Oct;113(1-2):14-26. doi: 10.1016/j.ymgme.2014.07.009. Epub 2014 Jul 16.
3
Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example.遗传性代谢缺陷的营养治疗:以苯丙酮尿症为例的适应证、规定和医学食品及膳食补充剂的供应情况。
Mol Genet Metab. 2012 Sep;107(1-2):3-9. doi: 10.1016/j.ymgme.2012.07.005. Epub 2012 Jul 16.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Medical Foods for Inborn Errors of Metabolism: History, Current Status, and Critical Need.代谢性疾病的医学食品:历史、现状和迫切需求。
Pediatrics. 2020 Mar;145(3). doi: 10.1542/peds.2019-2261. Epub 2020 Feb 7.
6
Developing treatments for inborn errors: incentives available to the clinician.开发先天性疾病的治疗方法:临床医生可获得的激励措施。
Mol Genet Metab. 2004 Apr;81 Suppl 1:S63-6. doi: 10.1016/j.ymgme.2003.10.015.
7
A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism.一种基于多重PCR的综合外显子组测序检测方法,用于快速通过血斑确认先天性代谢缺陷。
BMC Med Genet. 2019 Jan 6;20(1):3. doi: 10.1186/s12881-018-0731-5.
8
Phenylketonuria Scientific Review Conference: state of the science and future research needs.苯丙酮尿症科学审查会议:科学现状与未来研究需求
Mol Genet Metab. 2014 Jun;112(2):87-122. doi: 10.1016/j.ymgme.2014.02.013. Epub 2014 Mar 6.
9
Nutrition in the management of inborn errors of metabolism.先天性代谢缺陷病管理中的营养问题
Clin Lab Med. 1993 Jun;13(2):407-32.
10
Health-related quality of life in paediatric patients with intoxication-type inborn errors of metabolism: Analysis of an international data set.儿童中毒型先天性代谢缺陷患者的健康相关生活质量:国际数据集分析。
J Inherit Metab Dis. 2021 Jan;44(1):215-225. doi: 10.1002/jimd.12301. Epub 2020 Sep 22.

引用本文的文献

1
Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence.罕见神经疾病中的饮食与营养:生物学、生物化学和病理生理学证据。
Nutrients. 2024 Sep 15;16(18):3114. doi: 10.3390/nu16183114.
2
Impact of dietary interventions in inborn errors of metabolism in paediatric dentistry: Review of the literature and case series.饮食干预对儿科牙科先天性代谢缺陷的影响:文献综述与病例系列
Clin Case Rep. 2020 Dec 9;9(2):764-768. doi: 10.1002/ccr3.3603. eCollection 2021 Feb.
3
The changing landscape of clinical trials for mitochondrial diseases: 2011 to present.线粒体疾病临床试验的变化格局:2011 年至今。
Mitochondrion. 2020 Jan;50:51-57. doi: 10.1016/j.mito.2019.10.010. Epub 2019 Oct 25.
4
Effect of natural PAL-enzyme on the quality of egg white and mushroom flour and study its impact on the expression of PKU related genes and phenylalanine reduction in mice fed on.天然PAL酶对蛋清和蘑菇粉品质的影响及其对喂食小鼠苯丙酮尿症相关基因表达和苯丙氨酸降低的影响研究。
J Genet Eng Biotechnol. 2017 Dec;15(2):443-451. doi: 10.1016/j.jgeb.2017.07.010. Epub 2017 Oct 26.
5
Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.新生儿筛查连接系统(NBS connect)的开发:一个自我报告的患者登记系统及其在改善遗传性代谢疾病患者护理方面的作用。
Orphanet J Rare Dis. 2017 Jul 19;12(1):132. doi: 10.1186/s13023-017-0684-3.
6
A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias.对甲基丙二酸血症饮食疗法的批判性重新评估引发了对医用食品安全性的担忧。第1部分:孤立性甲基丙二酸血症。
Genet Med. 2016 Apr;18(4):386-95. doi: 10.1038/gim.2015.102. Epub 2015 Aug 13.
7
Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.当前在以氧化应激和线粒体功能障碍为特征的疾病中测试线粒体营养素的经验:化学预防试验的合理设计
Int J Mol Sci. 2014 Nov 5;15(11):20169-208. doi: 10.3390/ijms151120169.
8
Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning.通过新生儿筛查确定的先天性代谢缺陷:用于研究议程规划的十年发病率数据及营养干预成本
Mol Genet Metab. 2014 Sep-Oct;113(1-2):14-26. doi: 10.1016/j.ymgme.2014.07.009. Epub 2014 Jul 16.

本文引用的文献

1
A diversified approach for PKU treatment: routine screening yields high incidence of psychiatric distress in phenylketonuria clinics.PKU 治疗的多样化方法:常规筛查在苯丙酮尿症诊所中发现了很高的精神困扰发生率。
Mol Genet Metab. 2013 Jan;108(1):8-12. doi: 10.1016/j.ymgme.2012.11.003. Epub 2012 Nov 15.
2
The patient-centered medical home: this primary care model offers RNs new practice—and reimbursement—opportunities.患者为中心的医疗之家:这种基础医疗模式为注册护士提供了新的实践和报销机会。
Am J Nurs. 2012 Dec;112(12):54-9. doi: 10.1097/01.NAJ.0000423506.38393.52.
3
About half of the states are implementing patient-centered medical homes for their Medicaid populations.大约一半的州正在为其医疗补助人群实施以患者为中心的医疗之家。
Health Aff (Millwood). 2012 Nov;31(11):2432-40. doi: 10.1377/hlthaff.2012.0447.
4
Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases.嗜酸粒细胞性食管炎研究的跨部门赞助:罕见病合理药物开发的协作模式。
J Allergy Clin Immunol. 2012 Sep;130(3):613-6. doi: 10.1016/j.jaci.2012.07.011. Epub 2012 Jul 31.
5
Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example.遗传性代谢缺陷的营养治疗:以苯丙酮尿症为例的适应证、规定和医学食品及膳食补充剂的供应情况。
Mol Genet Metab. 2012 Sep;107(1-2):3-9. doi: 10.1016/j.ymgme.2012.07.005. Epub 2012 Jul 16.
6
Approaches to facilitate institutional review board approval of multicenter research studies.促进机构审查委员会批准多中心研究的方法。
Med Care. 2012 Jul;50 Suppl:S77-81. doi: 10.1097/MLR.0b013e31825a76eb.
7
Characteristics of rare disease marketing applications associated with FDA product approvals 2006-2010.2006-2010 年 FDA 批准的罕见病药物上市申请的特点。
Drug Discov Today. 2012 Aug;17(15-16):898-904. doi: 10.1016/j.drudis.2012.04.011. Epub 2012 May 5.
8
Diagnosing the decline in pharmaceutical R&D efficiency.诊断制药研发效率下降。
Nat Rev Drug Discov. 2012 Mar 1;11(3):191-200. doi: 10.1038/nrd3681.
9
Building a stronger foundation for a new century of treatments and cures.为新的世纪的治疗和治愈方法奠定更坚实的基础。
Health Aff (Millwood). 2011 Jan;30(1):81-3. doi: 10.1377/hlthaff.2010.0995.
10
Changes in the institutional review board submission process for multicenter research over 6 years.6 年来机构审查委员会提交多中心研究的流程变化。
Nurs Outlook. 2010 Jul-Aug;58(4):181-7. doi: 10.1016/j.outlook.2010.04.003.

扩大研究范围,为代谢性先天缺陷的营养干预管理提供证据基础。

Expanding research to provide an evidence base for nutritional interventions for the management of inborn errors of metabolism.

机构信息

Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Mol Genet Metab. 2013 Aug;109(4):319-28. doi: 10.1016/j.ymgme.2013.05.008. Epub 2013 May 23.

DOI:10.1016/j.ymgme.2013.05.008
PMID:23806236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4131198/
Abstract

A trans-National Institutes of Health initiative, Nutrition and Dietary Supplement Interventions for Inborn Errors of Metabolism (NDSI-IEM), was launched in 2010 to identify gaps in knowledge regarding the safety and utility of nutritional interventions for the management of inborn errors of metabolism (IEM) that need to be filled with evidence-based research. IEM include inherited biochemical disorders in which specific enzyme defects interfere with the normal metabolism of exogenous (dietary) or endogenous protein, carbohydrate, or fat. For some of these IEM, effective management depends primarily on nutritional interventions. Further research is needed to demonstrate the impact of nutritional interventions on individual health outcomes and on the psychosocial issues identified by patients and their families. A series of meetings and discussions were convened to explore the current United States' funding and regulatory infrastructure and the challenges to the conduct of research for nutritional interventions for the management of IEM. Although the research and regulatory infrastructure are well-established, a collaborative pathway that includes the professional and advocacy rare disease community and federal regulatory and research agencies will be needed to overcome current barriers.

摘要

一个跨国立卫生研究院的倡议,即营养和膳食补充剂干预先天性代谢缺陷(NDSI-IEM),于 2010 年启动,旨在确定在管理先天性代谢缺陷(IEM)方面,营养干预的安全性和实用性方面存在的知识空白,这些空白需要用循证研究来填补。IEM 包括遗传性生化障碍,其中特定的酶缺陷会干扰外源性(饮食)或内源性蛋白质、碳水化合物或脂肪的正常代谢。对于其中一些 IEM,有效的管理主要依赖于营养干预。需要进一步研究来证明营养干预对个体健康结果以及患者及其家属确定的心理社会问题的影响。为了探索目前美国在管理 IEM 的营养干预方面的研究的资金和监管结构以及所面临的挑战,举行了一系列会议和讨论。虽然研究和监管结构已经建立得很好,但需要一个包括专业和倡导罕见病社区以及联邦监管和研究机构的合作途径,以克服当前的障碍。